ZIOP Lakewood Capital Management

Lakewood Capital Opens Shorts In Seagate, Diplomat Pharmacy, Ziopharm Oncology

Lakewood Capital Management, the hedge fund managed by Anthony T. Bozza, recorded a net loss of 2.4% for the third quarter, according to the fund’s third quarter letter to partners reviewed by ValueWalk.

In Lakewood’s words the performance, “underscored the fund’s conservative orientation and careful approach to risk management”. Long equity positions generated a -9% return on capital, hedged long equity positions generated a -4% return on . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 9/130/2019 or after next 25 15 subscribers take advantage whichever comes first – please do not share this discount with others